Developing a novel algorithm to identify incident and prevalent dementia in Medicare claims—the ARIC Study.

There is an urgent need to improve dementia ascertainment robustness in real-world studies assessing drug effects on dementia risk. We developed algorithms to dementia identification algorithms using Medicare claims (inpatient/outpatient/prescription) from 3318 Visit 5 (2011-2013) and 1828 Visit 6 (...

Descripción completa

Detalles Bibliográficos
Publicado en:American Journal of Epidemiology Vol. 194; no. 12; pp. 3537 - 3549
Autores principales: Wang, Tiansheng, Pate, Virginia, Kim, Dae Hyun, Power, Melinda C, Garden, Gwenn, Palta, Priya, Knopman, David, Jonsson-Funk, Michelle, Stürmer, Til, Kucharska-Newton, Anna M
Formato: algorithm research tables/charts Journal Article
Publicado: Oxford University Press / USA Dec2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=189866692&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 189866692
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00029262
        1X1
      jtl: American Journal of Epidemiology
      issn: 00029262
      maglogo: N
    pubinfo:
      dt: Dec2025
      vid: 194
      iid: 12
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        189866692
        189866692
        189866692
        10.1093/aje/kwaf166
        189866692
      ppf: 3537
      ppct: 12
      formats:
      tig:
        atl: Developing a novel algorithm to identify incident and prevalent dementia in Medicare claims—the ARIC Study.
      aug:
        au:
          Wang, Tiansheng
          Pate, Virginia
          Kim, Dae Hyun
          Power, Melinda C
          Garden, Gwenn
          Palta, Priya
          Knopman, David
          Jonsson-Funk, Michelle
          Stürmer, Til
          Kucharska-Newton, Anna M
        affil: Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United StatesDepartment of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, TX 77204, United States
      sug:
        subj:
          Dementia Epidemiology
          Dementia Diagnosis
          Medicare
          Billing and Claims
          Algorithms
          Dementia Risk Factors
          Risk Assessment
          Instrument Construction
          Instrument Validation
          Human
          Funding Source
          Male
          Female
          Aged
          Prospective Studies
          Validation Studies
          Random Sample
          Sensitivity and Specificity
          Predictive Value of Tests
          Comparative Studies
          Dementia Classification
          Aged, 80 and Over
          Descriptive Statistics
          Data Analysis Software
          Neuropsychological Tests
          Scales
          Aged: 65+ years
          Aged, 80 & over
          Male
          Female
      ab: There is an urgent need to improve dementia ascertainment robustness in real-world studies assessing drug effects on dementia risk. We developed algorithms to dementia identification algorithms using Medicare claims (inpatient/outpatient/prescription) from 3318 Visit 5 (2011-2013) and 1828 Visit 6 (2016-2017) participants of the Atherosclerosis Risk in Communities (ARIC) Study, validated against ARIC's rigorous syndromic dementia classification. Algorithm performance was compared to existing algorithms (Jain, Bynum, Lee). We further evaluated algorithms effectiveness in a 20% random Medicare sample aged ≥70 years who initiating liraglutide or dipeptidyl peptidase 4 inhibitors (DPP4i) to assess 3-year adjusted risk difference (aRD) for dementia. Our incident dementia algorithm required two dementia diagnostic codes within 1-year, or one dementia code plus a new dementia prescription within 90 days. It achieved a positive predictive value (PPV) of 69.2%, specificity of 99.0%, and sensitivity of 34.6% (population prevalence: 8.8%), comparable to extant algorithms (PPV, 58.7–68.6%; sensitivity 25.5–40.4%). Prevalent dementia algorithm (without requiring incident diagnoses/prescriptions) demonstrated similar performance. In the Medicare sample, dementia risk ranged from 3.0% to 12.5%, aRD comparing liraglutide to DPP4i varied −1.2% to −3.6%, with our algorithm closely matching the Bynum algorithm. Algorithm selection significantly impacts treatment effect estimates, highlighting its importance in in pharmacoepidemiologic research.
      pubtype: Academic Journal
      doctype:
        algorithm
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N